Cargando…

Organisation of diagnosis and treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases in the Nordic countries

INTRODUCTION: Differences in the organisation of idiopathic pulmonary fibrosis (IPF) and interstitial lung diseases (ILDs) in the Nordic countries are not well described. Diagnostic setups, treatment modalities and follow-up plans may vary due to national, cultural and epidemiological features. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bendstrup, Elisabeth, Hyldgaard, Charlotte, Altraja, Alan, Sjåheim, Tone, Myllärniemi, Marjukka, Gudmundsson, Gunnar, Sköld, Magnus, Hilberg, Ole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Co-Action Publishing 2015
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629764/ https://www.ncbi.nlm.nih.gov/pubmed/26557259 http://dx.doi.org/10.3402/ecrj.v2.28348

Ejemplares similares

International multidisciplinary team discussions on the diagnosis of idiopathic non-specific interstitial pneumonia and the development of connective tissue disease
por: Møller, Janne, et al.
Publicado: (2021)

Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries
por: Pesonen, Ida, et al.
Publicado: (2018)

Economic consequences of idiopathic pulmonary fibrosis in Denmark
por: Hilberg, Ole, et al.
Publicado: (2018)

Clinical characteristics and outcome in patients with antisynthetase syndrome associated interstitial lung disease: a retrospective cohort study
por: Jensen, Mads Lynge, et al.
Publicado: (2019)

Changes in management of idiopathic pulmonary fibrosis: impact on disease severity and mortality
por: Hyldgaard, Charlotte, et al.
Publicado: (2020)

Validation of the King’s Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis
por: Prior, Thomas Skovhus, et al.
Publicado: (2019)

Incidence, prevalence and regional distribution of systemic sclerosis and related interstitial lung Disease: A nationwide retrospective cohort study
por: Knarborg, Malene, et al.
Publicado: (2022)

Comorbidity and mortality in systemic sclerosis and matched controls: Impact of interstitial lung disease. A population based cohort study based on health registry data
por: Knarborg, Malene, et al.
Publicado: (2023)

No effect of pirfenidone treatment in fulminant bleomycin-induced pneumonitis
por: Bendstrup, Elisabeth, et al.
Publicado: (2014)

NT-proBNP <95 ng/l can exclude pulmonary hypertension on echocardiography at diagnostic workup in patients with interstitial lung disease
por: Andersen, Charlotte, et al.
Publicado: (2016)

Intravenous immunoglobulin treatment stabilizing a patient with Anti-PL7 antisynthetase syndrome with interstitial lung disease and eosinophilic inflammation
por: Peshbahar, Soran, et al.
Publicado: (2022)

Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
por: Myllärniemi, Marjukka, et al.
Publicado: (2015)

Emphysema mimicking interstitial lung disease: Two case reports
por: Juhl, Kasper S., et al.
Publicado: (2014)

Palliation of chronic breathlessness with morphine in patients with fibrotic interstitial lung disease – a randomised placebo-controlled trial
por: Kronborg-White, Sissel, et al.
Publicado: (2020)

Responsiveness and minimal clinically important difference of SGRQ-I and K-BILD in idiopathic pulmonary fibrosis
por: Prior, Thomas Skovhus, et al.
Publicado: (2020)

Tele-Rehabilitation Program in Idiopathic Pulmonary Fibrosis—A Single-Center Randomized Trial
por: Cerdán-de-las-Heras, Jose, et al.
Publicado: (2021)

Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians
por: Bendstrup, Elisabeth, et al.
Publicado: (2019)

Interstitial Lung Disease in Connective Tissue Diseases: Survival Patterns in a Population-Based Cohort
por: Hyldgaard, Charlotte, et al.
Publicado: (2021)

Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data
por: Kaunisto, Jaana, et al.
Publicado: (2013)

Comorbidities in unclassifiable interstitial lung disease
por: Prior, Thomas Skovhus, et al.
Publicado: (2022)

Overall drug treatment of idiopathic pulmonary fibrosis patients from national registries – a real-world study from Finland
por: Kaunisto, Jaana, et al.
Publicado: (2023)

mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis
por: Rajala, Kaisa, et al.
Publicado: (2017)

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
por: Kaunisto, Jaana, et al.
Publicado: (2019)

Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD
por: Ishikawa, Nobuhisa, et al.
Publicado: (2010)

KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis
por: Hollmén, Maria, et al.
Publicado: (2023)

Increasing awareness of corticosteroid hypersensitivity reactions is important
por: Knarborg, Malene, et al.
Publicado: (2013)

Design and rationale of ProSar, the first Danish sarcoidosis registry
por: Møller, Janne, et al.
Publicado: (2021)

Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis
por: Seppälä, Severi, et al.
Publicado: (2020)

Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways
por: Saraswat, Mayank, et al.
Publicado: (2020)

Eosinophil alveolitis in two patients with idiopathic pulmonary fibrosis
por: Brix, Ninna, et al.
Publicado: (2016)

PRS-ing Forward to Identify Genetic Risk in Idiopathic Pulmonary Fibrosis
por: Blackwell, Timothy S., et al.
Publicado: (2023)

Are physicians in primary health care able to recognize pulmonary fibrosis?
por: Purokivi, Minna, et al.
Publicado: (2017)

PD-L1 Expression in Patients with Idiopathic Pulmonary Fibrosis
por: Kronborg-White, Sissel, et al.
Publicado: (2021)

Risk factors for diagnostic delay in idiopathic pulmonary fibrosis
por: Hoyer, Nils, et al.
Publicado: (2019)

Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results
por: Salih, Goran Nadir, et al.
Publicado: (2016)

Gender differences at presentation of idiopathic pulmonary fibrosis in Sweden
por: Kalafatis, Dimitrios, et al.
Publicado: (2019)

Familial idiopathic pulmonary fibrosis in a young female
por: Sritharan, Sajitha S., et al.
Publicado: (2018)

Tracheal collapse diagnosed by multidetector computed tomography: evaluation of different image analysis methods
por: Nygaard, Mette, et al.
Publicado: (2017)

Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment – A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine
por: Koli, Katri, et al.
Publicado: (2016)

End-of-life care of patients with idiopathic pulmonary fibrosis
por: Rajala, Kaisa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9m23dmil587p5akj3j74kt3f90